Methylphenidate-osmotic-controlled release oral delivery system treatment reduces parenting stress in parents of children and adolescents with attention-deficit/hyperactivity disorder.
about
Differences in Utilization Patterns among Medications in Children and Adolescents with Attention-Deficit/Hyperactivity Disorder: a 36-Month Retrospective Study Using the Korean Health Insurance Review and Assessment Claims Database.Relationships between behavioral symptoms of non-medicated Chinese children with attention deficit hyperactivity disorder and parenting stress: Comparison of different subtypes and comorbidities.
P2860
Methylphenidate-osmotic-controlled release oral delivery system treatment reduces parenting stress in parents of children and adolescents with attention-deficit/hyperactivity disorder.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh-hant
name
Methylphenidate-osmotic-contro ...... eficit/hyperactivity disorder.
@en
Methylphenidate-osmotic-contro ...... eficit/hyperactivity disorder.
@nl
type
label
Methylphenidate-osmotic-contro ...... eficit/hyperactivity disorder.
@en
Methylphenidate-osmotic-contro ...... eficit/hyperactivity disorder.
@nl
prefLabel
Methylphenidate-osmotic-contro ...... eficit/hyperactivity disorder.
@en
Methylphenidate-osmotic-contro ...... eficit/hyperactivity disorder.
@nl
P2093
P2860
P356
P1476
Methylphenidate-osmotic-contro ...... eficit/hyperactivity disorder.
@en
P2093
Bongseog Kim
Chul-Ho Jung
Dong-Won Shin
Hanik K Yoo
Heejeong Yoo
Jeong-Seop Lee
Jong-Hun Lee
Jun-Won Hwang
Myung-Ho Lim
Tae-Ho Kim
P2860
P304
P356
10.1002/HUP.2363
P577
2013-11-01T00:00:00Z